Mylan Laboratories Inc. won U.S. regulatory approval for a generic version of Pfizer Inc.’s blood-pressure pill Norvasc. The Food and Drug Administration confirmed that Mylan was the first to file for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback